This is a preview of subscription content, log in via an institution to check access.
References
Vardiman JW, Melo JV, Baccarani M, Thiele J. Chronic myelogenous leukaemia, BCR-ABL1 positive. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. p. 32–7.
Iriyama N, Hatta Y, Kobayashi S, Uchino Y, Miura K, Kurita D, et al. The European treatment and outcome study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemia. Int J Hematol. 2014;100:379–85.
Galli SJ, Metcalfe DD, Arber DA, Dvorak AM. Basophils and mast cells and their disorders. In: Kaushansky K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT, editors. Williams Hematology. 8th ed. New York: McGraw-Hill; 2010. p. 915–32.
Spiers AS, Bain BJ, Turner JE. The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases. Scand J Haematol. 1977;18:25–38.
Conflict of interest
MK received research funding, lecture fee and advisory fee from Novartis Pharmaceuticals, research funding, lecture fee and advisory fee from Bristol-Myers. YN received lecture fee from Novartis Pharmaceuticals, lecture fee and advisory fee from Bristol-Myers.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Masuda, A., Jona, M., Satoh, Y. et al. The criteria to suspect chronic myeloid leukemia using absolute basophil counts in peripheral blood. Int J Hematol 101, 626–628 (2015). https://doi.org/10.1007/s12185-015-1777-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-015-1777-1